Aptose Biosciences (APTO) Misses Q4 EPS by 34c
Get Alerts APTO Hot Sheet
Join SI Premium – FREE
Aptose Biosciences (NASDAQ: APTO) reported Q4 EPS of ($0.45), $0.34 worse than the analyst estimate of ($0.11).
For earnings history and earnings-related data on Aptose Biosciences (APTO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gordon Haskett cuts TJX Companies rating to Accumulate
- Wolfspeed (WOLF) Misses Q4 EPS by 174c; Offers Guidance
- Youdao, Inc. (DAO) Tops Q2 EPS by 50c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share